Literature DB >> 3294878

Sequential changes in plasma luteinizing hormone and plasma prorenin during the menstrual cycle.

J E Sealey, I Cholst, N Glorioso, C Troffa, I D Weintraub, G James, J H Laragh.   

Abstract

Prorenin, the enzymatically inactive biosynthetic precursor of renin, is secreted by the kidneys. However, the ovaries appear to be the source of the cyclical increase in plasma prorenin that occurs in the middle of the menstrual cycle. In this study we examined the temporal relationship between changes in plasma prorenin and LH in normal women to determine whether ovarian prorenin secretion might be stimulated by LH. Blood was collected from nine normal women daily for 7 days in the midcycle period and from six of them every 8 h on 6 of these days. Time zero was taken as the highest plasma LH value. The initial rise in LH (-24 h) preceded the initial rise in prorenin (-8 h) and the LH peak preceded the prorenin peak by 8-16 h. These sequential increases in plasma LH and prorenin occurred in the presence of high plasma estradiol levels. While LH fell in parallel with estradiol, the prorenin peak was more sustained and plasma prorenin remained above baseline at 40 and 48 h, at a time when both estradiol and LH had reached a new basal level. These results suggest that gonadotropins stimulate ovarian prorenin release. The timing of the changes in plasma prorenin and its presence in high concentrations in ovarian follicular fluid suggest that prorenin may be involved in the process of ovulation. The results also suggest that changes in plasma prorenin may determine the activity of an ovarian renin system that functions independently of circulating active renin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3294878     DOI: 10.1210/jcem-65-1-1

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

Review 1.  Ovarian hyperstimulation syndrome: a review of pathophysiology.

Authors:  P A Bergh; D Navot
Journal:  J Assist Reprod Genet       Date:  1992-10       Impact factor: 3.412

2.  Plasma prorenin response to human chorionic gonadotropin in ovarian-hyperstimulated women: correlation with the number of ovarian follicles and steroid hormone concentrations.

Authors:  J Itskovitz; J E Sealey; N Glorioso; Z Rosenwaks
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

3.  Interactions between insulin-like growth factor-I (IGF-I) and the renin-angiotensin system in follicular growth and ovulation.

Authors:  Y Yoshimura; N Aoki; K Sueoka; T Miyazaki; N Kuji; M Tanaka; T Kobayashi
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

4.  Estrogen delays the progression of salt-induced cardiac hypertrophy by influencing the renin-angiotensin system in heterozygous proANP gene-disrupted mice.

Authors:  S Jeson Sangaralingham; M Yat Tse; Stephen C Pang
Journal:  Mol Cell Biochem       Date:  2007-08-23       Impact factor: 3.396

5.  Primary aldosteronism caused by an adrenal tumor: a correctable cause of hypertension.

Authors:  R J Smith; W L Faulkner
Journal:  J Natl Med Assoc       Date:  1993-10       Impact factor: 1.798

6.  Gonadotropin stimulates ovarian renin-angiotensin system in the rabbit.

Authors:  Y Yoshimura; N Koyama; M Karube; T Oda; M Akiba; A Yoshinaga; S Shiokawa; M Jinno; Y Nakamura
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

7.  Determinants of Maternal Renin-Angiotensin-Aldosterone-System Activation in Early Pregnancy: Insights From 2 Cohorts.

Authors:  Rosalieke E Wiegel; A H Jan Danser; Régine P M Steegers-Theunissen; Joop S E Laven; Sten P Willemsen; Valerie L Baker; Eric A P Steegers; Frauke von Versen-Höynck
Journal:  J Clin Endocrinol Metab       Date:  2020-11-01       Impact factor: 5.958

8.  Expression of the DBA/2J Ren-2 gene in the adrenal gland of transgenic mice.

Authors:  J J Mullins; C D Sigmund; C Kane-Haas; K W Gross; R A McGowan
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

9.  Increased total Renin levels but not Angiotensin-converting enzyme activity in obese patients with polycystic ovary syndrome.

Authors:  Ziynet Alphan; Zehra Berberoglu; Suheyla Gorar; Zehra Candan; Aynur Aktas; Yalcin Aral; Esranur Ademoglu
Journal:  Med Princ Pract       Date:  2013-07-26       Impact factor: 1.927

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.